✦ LIBER ✦

O-186 Mutations in EGFR, HER2, KRAS and BRAF in NSCLC: Prevalences and correlations with clinical outcomes in patients treated with carboplatin and paclitaxel with or without erlotinib

✍ Scribed by Eberhard, D.; Johnson, B.; Goddard, A.; Herbst, R.; Janne, P.; Johnson, D.; Klein, P.; Ostland, M.; Seshagiri, S.; Hillan, K.

Book ID: 118572734
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 185 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80320-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

24 Outcome in metastatic NSCLC without E

24 Outcome in metastatic NSCLC without EGFR and KRAS mutation treated with second line erlotinib

✍ Dua, D.; Montes, A.; Warner, M.; Spicer, J.; Lal, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Correlation of Somatic Mutations and Cli

Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and Sorafenib

✍ Wilson, M. A.; Zhao, F.; Letrero, R.; D'Andrea, K.; Rimm, D. L.; Kirkwood, J. M. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 386 KB

PD-143 Analysis of EGFr gene mutations i

PD-143 Analysis of EGFr gene mutations in non-small cell lungcarcinoma (NSCLC) patients (pts) treated with panitumumab plus paclitaxel and carboplatin or chemotherapy alone

✍ Freeman, D.; Juan, T.; Sarosi, I.; Crawford, J.; Sandler, A.; Schiller, J.; Prag 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The Impact of EGFR T790M Mutations and B

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

✍ Costa, C.; Molina, M. A.; Drozdowskyj, A.; Gimenez-Capitan, A.; Bertran-Alamillo 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 651 KB

EGFR mutations and HER2/3 protein expres

EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib

✍ Jian Ming Xu; Yu Han; Hai Qing Duan; E. Mei Gao; Yang Zhang; Xiao Qing Liu; Jing 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 521 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB